Home » PAR PHARMA RECORDS $35M QUARTERLY LOSS
PAR PHARMA RECORDS $35M QUARTERLY LOSS
Par Pharmaceutical Cos. reported today that it lost $34.9 million, or $1.02
a share, during the fourth quarter, brought down in large measure by charges
related to the sale of its FineTech Laboratories Ltd. unit. A year ago, Woodcliff
Lake, N.J.-based Par reported net income of $5.2 million, or 14 cents a share,
for the three months ending Dec. 31, 2004. Par has major operations in Chestnut
Ridge.
The
Journal News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May